Martin Voss (@mvossmd) 's Twitter Profile
Martin Voss

@mvossmd

GU Oncologist,
Memorial Sloan Kettering Cancer Center, New York
@MSKCC

ID: 1273304237691342848

linkhttps://www.mskcc.org/cancer-care/doctors/martin-voss calendar_today17-06-2020 17:19:45

2 Tweet

290 Followers

45 Following

Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo
Toni Choueiri, MD
@drchoueiri

a year ago

Interesting RWD showing superior clinical outcomes in 1L with doublet regimens containing targeted therapy compared to monotherapies in pts with #chromophobe RCC! Martin Voss ASCO OncoAlert #ASCO24

Interesting RWD showing superior clinical outcomes in 1L with doublet regimens containing targeted therapy compared to monotherapies in pts with #chromophobe RCC! <a href="/MVossMD/">Martin Voss</a> <a href="/ASCO/">ASCO</a> <a href="/OncoAlert/">OncoAlert</a> #ASCO24
Gʀᴇɢᴏʀʏ Rɪᴇʟʏ (@rielymd) 's Twitter Profile Photo
Gʀᴇɢᴏʀʏ Rɪᴇʟʏ
@rielymd

a year ago

I love early phase studies evaluating a clear hypothesis, with rich correlatives. Great example from ⁦Ritesh Kotecha⁩ ⁦MSK Department of Medicine⁩ looking at talazoparib and axitinib in pts with kidney cancer #ASCO24 ⁦Martin Voss⁩

I love early phase studies evaluating a clear hypothesis, with rich correlatives. Great example from ⁦<a href="/KotechaMD/">Ritesh Kotecha</a>⁩ ⁦<a href="/MSK_DeptOfMed/">MSK Department of Medicine</a>⁩ looking at talazoparib and axitinib in pts with kidney cancer #ASCO24 ⁦<a href="/MVossMD/">Martin Voss</a>⁩